Partner of Quebec man who received MAID after bedsores says hospital ignored her

MONTREAL — Sylvie Brosseau said she and her partner Normand Meunier dreamed of buying an adapted camper where, despite his quadriplegia, they could indulge their shared love of the outdoors, and spend time with their children and grandchildren.
All that changed after Meunier was left on a stretcher at a hospital north of Montreal for 96 hours and developed a severe pressure sore that never healed, Brosseau said Thursday outside the Montreal courtroom where a coroner is holding hearings into Meunier's death.
Meunier, who was 66, requested medical assistance in dying two months after developing the sore and died March 29, 2024.
"Despite his quadriplegia, he still had plans he wished to realize, he had lofty goals," Brosseau said. "But because of the incurable bedsore that appeared at the hospital, he had no more perspective on life."
Brosseau says she repeatedly asked hospital staff to give Meunier a special therapeutic mattress that prevents sores, but she says she felt ignored.
"They cared very little about me," she said prior to her testimony at the coroner's inquest.
She brought photos of the couple's life together, including one showing Meunier grinning broadly while surrounded by grandchildren. She said she wanted people to remember that side of him, and not only for graphic photos of the gaping wound on his buttock that one nurse would describe as the biggest she'd ever seen.
Coroner Dave Kimpton is presiding over the investigation into Meunier's death. The inquest, which began May 5, is also hearing from police, medical personnel, and experts who will offer recommendations.
In her testimony Thursday afternoon, Brosseau said bedsores were 'always a worry' because Meunier had developed them during previous hospital stays.
She testified that her partner had been taken to St-Jérôme hospital on Jan. 18, 2024, with respiratory issues. She said she had told the medical staff that he was prone to sores and advised them of the equipment he needed, including a therapeutic mattress.
However, she said Meunier remained on a stretcher for four days before he was taken to intensive care. After a two-day stay in intensive care, he was transferred to another unit on Jan. 26, where Brosseau said the proper equipment again wasn't provided.
When she questioned one of his doctors about a mattress, she was told, "you are lucky, I saved his life," she testified. He told her that securing a therapeutic mattress would be handled by others.
"For him, it was part of the decor," she said of the mattress.
Meunier was let out of hospital on Jan. 29. The next day, the medical staff who came to treat him at home saw the sore and was shocked, she said.
Brosseau became tearful when she described seeing the wound on Feb. 5, after her husband's caretakers convinced the family Meunier needed to return to hospital.
"I never saw something like that," she said. "It's unimaginable.'
Brosseau said that throughout her husband's multiple hospital stays, she continually had to fight for him to get the supplies he needed, including mattresses, sheets and bandages adapted to his needs. Meunier requested medical assistance in dying in early March, after his condition had continued to decline.
He died on March 29, surrounded by family and with his chosen music playing. "He left how he wanted," she said.
At the conclusion of her testimony, Kimpton told Brosseau he was "shaken" by her testimony, and praised her dedication to her partner. "He was lucky to have a warrior at his side," the coroner told her.
Brosseau's lawyer, Patrick Martin-Ménard, said outside the courtroom that Meunier's story shows that bedsores, and the care of those susceptible to them, remain a "blind spot" in the health system.
"What we saw throughout this inquest is that throughout Mr. Meunier's stay, there was very little awareness on the part of the professionals who should have been trained to be able to monitor this situation," he said.
Martin-Ménard said the testimony from hospital staff showed "little introspection" or willingness to take responsibility for what happened to Meunier. He said he hoped the inquest results in a stronger system that will proactively identify and address the needs of people at risk of bedsores at every step of their journey through the health network.
This report by The Canadian Press was first published May 15, 2025.
Morgan Lowrie, The Canadian Press

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Medscape

21 minutes ago

• Medscape

ASCO 2025: New Standards Reshape Care in mBC

Heather McArthur, MD, describes how the 2025 ASCO Annual Meeting brought exciting advances in the metastatic breast cancer space. In PD-L1-positive triple-negative breast cancer, sacituzumab govitecan combined with pembrolizumab significantly improved progression-free survival over standard chemotherapy plus pembrolizumab, quickly becoming a new standard of care. Similarly, in HER2-positive disease, trastuzumab deruxtecan combined with pertuzumab outperformed traditional THP therapy, offering a new frontline option. Overall, these findings signify a major shift in how to treat metastatic breast cancer.

Health Line

22 minutes ago

• Health Line

Stages of Crohn's Disease

Key takeaways Crohn's disease symptoms can be mild, moderate, or severe. It's a progressive disease, but its stages are hard to determine because each person's condition progresses differently. The earlier you treat and manage Crohn's, the more likely you are to reduce your chance of developing more severe symptoms. There's no cure for Crohn's disease, but medications and lifestyle changes can help manage the condition. This is why it's crucial to identify the disease when symptoms are still mild. Crohn's disease is a type of inflammatory bowel disease (IBD). It's considered a chronic condition, which means that you'll have it for your entire life. The exact cause of Crohn's is unknown. It most often develops in your late teens or 20s. Crohn's disease is marked by inflammation of the gastrointestinal (GI) tract. The inflammation can appear anywhere in the GI tract, from the mouth to the anus. What are the stages of Crohn's disease? Crohn's is a progressive disease that starts with mild symptoms and gradually gets worse. With mild to moderate Crohn's, you may experience diarrhea or abdominal pain, but you won't experience other symptoms or complications. You're able to move, eat, and drink as normal, and the disease has a minimal impact on your quality of life. In some cases, you won't even require treatment. If you have moderate to severe Crohn's disease, you may experience diarrhea or abdominal pain, as well as additional symptoms and complications, such as fever or anemia. If your Crohn's is severe, you might be in constant pain and discomfort, and you may need to use the bathroom frequently. That said, it's difficult to classify Crohn's disease into stages because people tend to experience ups and downs in symptoms. What progression looks like can be different for each person, and treatment can affect your outlook. How quickly does Crohn's disease progress? Over time, Crohn's can cause damage to the intestines and lead to potential complications such as strictures, fistulas, and abscesses. Stricture means that a portion of the intestine becomes narrower due to scar tissue on its wall. While there's no time frame for how long it would take for such complications to develop, there are risk factors that may speed up progression. These include: being under 30 years old having a history of smoking having ulcers found in a colonoscopy having the long bowel segments affected by the disease having anal inflammation having symptoms that go beyond the intestinal system, such as in the eyes, skin, liver, or joints having a history of bowel resections At diagnosis, 10% of people already have strictures, and an additional 15% to 20% will develop them within the next 10 to 20 years. Five types of Crohn's disease Progression may also depend on the type of Crohn's disease you have. These are: ileocolitis ileitis gastroduodenal Crohn's disease diffuse jejunoileitis Crohn's colitis Crohn's disease progression patterns The patterns by which Crohn's might progress are: Chronic relapsing: With this progression type, you typically experience at least 12 months of remission before experiencing a flare. Common symptoms of a Crohn's disease flare-up may include diarrhea, abdominal pain, weight loss, blood in stool, and fatigue. Remission: Remission means that your symptoms improve or disappear completely. Various studies show most people will relapse within 8 years of diagnosis, with a 43% to 45% remission rate after 10 years. But if you stay in remission for a year, there's an 80% chance remission will continue for the next year. Improved and stable: This is when your condition has progressed to having no symptoms and has remained this way, though signs of the disease might still show up on tests. Chronic refractory: This means you continue to show symptoms without any breaks or remission. About 10% to 15% of people with Crohn's experience a chronic refractory disease course. That said, even different people living with the same Crohn's pattern might progress differently. Genetics, type of treatment, and surgery are also factors that may affect which disease course you follow. The earlier you treat and manage Crohn's, the more likely you are to reduce your chance of developing more severe symptoms. What is the life expectancy of someone with Crohn's disease? There's no cure for Crohn's disease, though many people can live fulfilling lives with long periods of remission. That said, although there's been an increase in life expectancy for people living with inflammatory bowel diseases (IBDs), the life expectancy of Crohn's is still lower compared to those without IBDs for both males and females. When Crohn's causes complications, it can, in rare cases, lead to death. Common causes of death include cancer, heart disease, and infection. What are the early symptoms of Crohn's disease? In Crohn's disease, healthy cells in the GI tract attack themselves, causing inflammation. As a result, you'll likely experience a range of symptoms. Early signs of Crohn's disease include: frequent cramps ongoing abdominal pain frequent diarrhea bloody stools unintentional weight loss As the disease progresses, you may start feeling fatigued and even develop anemia. You may also experience nausea from constant irritation of the GI tract. In addition, you may start experiencing symptoms outside of the GI tract. These symptoms include: eye pain fever joint inflammation and pain red skin rashes and bumps mouth sores Early diagnosis is important to help prevent damage to the intestines. If you experience these symptoms and have a family history of Crohn's, you should ask your doctor for testing. How is Crohn's disease treated and managed? Medications can treat inflammation and stop your body from attacking its own cells. As your symptoms progress, your gastroenterologist may also recommend occasional bowel rest. However, not all doctors agree with this measure. A bowel rest involves a strict diet of only liquids for a few days. The purpose is to let the GI tract heal from inflammation and essentially take a break. To prevent malnutrition, you may need an IV. Talk with your doctor before switching to a liquid diet. Following this, your doctor may follow a special Crohn's diet and take supplements. You also may need to take pain medication. Avoid nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin), as these can make Crohn's worse. Instead, ask your doctor if you can safely take acetaminophen (Tylenol). You may need surgery if your symptoms become life threatening. Around 67% to 75% of all people with Crohn's will eventually need surgery, according to the Crohn's & Colitis Foundation. Surgery can't cure the disease, but it may help repair severely damaged tissues and remove blockages.

Medscape

an hour ago

• Medscape

ICML 2025

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out